ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Multiple Sclerosis
Sclerosis
Chronic Progressive Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Autoimmune Diseases
Neoplasm Metastasis
Alzheimer Disease

Multiple Sclerosis (MS) trials near London, England, GBR:

Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis (KATHAROS)

This study will evaluate whether ofatumumab is excreted at quantifiable levels and at which concentrations in breast milk of lactating women with RMS...

Enrolling
Multiple Sclerosis
Drug: Ofatunumab

Phase 4

Novartis
Novartis

London, United Kingdom and 16 other locations

This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who...

Active, not recruiting
Multiple Sclerosis
Drug: Ocrelizumab

Phase 3

Roche
Roche

London, United Kingdom and 156 other locations

The study seeks to investigate safety and efficacy of ixazomib (NINLARO), a proteasome inhibitor, in multiple sclerosis (MS...

Enrolling
Primary Progressive Multiple Sclerosis
Secondary Progressive Multiple Sclerosis
Drug: Ixazomib (NINLARO®) capsules / Matching placebo capsules

Phase 1

Queen Mary University of London

London, Greater London, United Kingdom

Multiple Sclerosis (MS) is a long-term disease that affects over 150,000 people in the UK. Starting treatment early is imp ...

Enrolling
Multiple Sclerosis
Device: AI software
Queen Mary University of London

London, United Kingdom

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Active, not recruiting
Multiple Sclerosis
Drug: Interferon beta-1a
Drug: Placebo capsule

Phase 3

Novartis
Novartis

London, United Kingdom and 72 other locations

effects of alemtuzumab on other multiple sclerosis (MS) disease characteristics such as cognition and quality of life (Qo...

Active, not recruiting
Multiple Sclerosis
Drug: Dexchlorpheniramine
Drug: Methylprednisolone

Phase 3

Genzyme
Genzyme

London, London, City Of, United Kingdom and 20 other locations

This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis...

Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Placebo
Drug: Obexelimab

Phase 2

Zenas BioPharma

London, United Kingdom and 46 other locations

This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...

Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
Drug: Ocrelizumab
Drug: Fingolimod

Phase 3

Roche
Roche

London, United Kingdom and 105 other locations

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Multiple Sclerosis
Drug: Remibrutinib
Drug: Teriflunomide

Phase 3

Novartis
Novartis

London, United Kingdom and 239 other locations

New

The main purpose of this study is to evaluate if obe-cel is safe or causes any side effects in adults with refractory progressive MS. The st...

Enrolling
Progressive Multiple Sclerosis
Biological: Obecabtagene autoleucel (obe-cel)

Phase 1

Autolus

London, United Kingdom

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems